Nanovehicles: An efficient carrier for active molecules for entry into the cell

International Journal of Pharmaceutical Sciences Review and Research

Volumn 4, Issue 3, 2010, Pages 15-22

  Pattnaik, Gurudatta ^a   Raju, K Siva Rama ^a   Heeralal, B ^a   Ali, Md Sajid ^a  

^a National Institute of Pharmaceutical Education and Research (NIPER)   (India)

Author keywords

Caveolae; Clathrin; Endocytosis; Macropinocytosis; Nanoparticles; Phagocytosis

Indexed keywords

AMPHIPHYSIN; CHITOSAN; CLATHRIN; DYNAMIN; FLUORESCENT DYE; GLIBENCLAMIDE; INTERSECTIN; MACROGOL; MOLECULAR SCAFFOLD; NANOCARRIER; POLYSTYRENE; SILICON DIOXIDE;

ARTICLE; CAVEOLA; CAVEOLA MEDIATED ENDOCYTOSIS; CELL MEMBRANE TRANSPORT; CELL MIGRATION; CELL SPECIFICITY; CELLULAR DISTRIBUTION; CLATHRIN MEDIATED PINOCYTOSIS; DRUG DELIVERY SYSTEM; ENDOCYTOSIS; INFECTION; INTERNALIZATION; INTRACELLULAR SPACE; INTRACELLULAR TRANSPORT; LIGAND BINDING; MACROPINOCYTOSIS; MATERIAL COATING; MOLECULAR DYNAMICS; MOLECULAR IMAGING; MOLECULAR PROBE; NANOPHARMACEUTICS; NONHUMAN; PARTICLE SIZE; PHAGOCYTOSIS; PHYSICAL CHEMISTRY; PINOCYTOSIS; SURFACE PROPERTY;

EID: 79952026818     PISSN: None     EISSN: 0976044X     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Colvin V L, The potential environmental impact of engineered nanomaterials, Nat Biotechnology, 2, 2003, 11166- 70.
2. Service R F, American Chemical Society meeting, Nanomaterials show signs of toxicity, Science, 300, 2003, 243.
3. Duncan R, The dawning era of polymer therapeutics, Nature Review Drug Discovery, 2, 2003, 347-360.
4. Farokhzad O C, Langer R, Nanomedicine: developing smarter therapeutic and diagnostic modalities, Adv Drug Del Rev, 58, 2006, 1456-1459.
5. Couvreur C, Robert T L, Poupon M F, Brasseur F and Puisieux F, Nanoparticles as microcarriers for anti cancer drugs, Adv Drug Del Review, 5, 1990, 209-230.
6. Kam N W, Jessop T C, Wender P A, Dai H J, Nanotube molecular transporters: internalization of carbon nanotube-protein conjugates into mammalian cells, Jour Am Chem Soc, 126, 2004, 6850 -6851.
7. Derfus A M, Chan W C, Bhatia S, Probing the cytotoxicity of semiconductor quantum dots, Nano Lett, 4, 2004, 11 - 18.
8. Thomas M, Klibanov A M, Conjugation to gold nanoparticles enhances polyethylenimine's transfer of plasmid DNA into mammalian cells, Proc Natl Acad Sci U S A, 100, 2003, 9138 -9143
9. Rajendran L, Knolker H J, Simons K, Subcellular targeting strategies for drug design and delivery, Nature Review Drug Discovery, 9, 2010, 29-42.
10. Oh P, Borgstrom P, Witkiewicz H, Li Y, Borgstrom B J et. al., Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung, Nature Biotechnology, 25, 2007, 327-337.
11. Vasir J K, Labhasetwar V, Quantification of the force of nanoparticle-cellmembrane interactions and its influence on intracellular trafficking of nanoparticles, Biomaterials, 29, 2008, 4244-4252.
12. Gumbleton M, Stephens D J, Coming out of the dark: the evolving role of fluorescence imaging in drug delivery research, Adv Drug Del Rev, 2005, 57, 5-15.
13. Marko Kaksonen, Christopher P. Toret & David G. Drubin, Harnessing actin dynamics for clathrinmediated endocytosis, Nature Reviews Molecular Cell Biology, 2006, 7, 407-414.
14. Merrifield C J, Perrais D & Zenisek D, Coupling between clathrin-coated-pit invagination, cortactin recruitment and membrane scission observed in live cells, Cell, 121, 2005, 593-606.
15. Siddhartha S, Nanomedicines: physiological principles of distribution, Digest Journal of Nanomaterials and Biostructures, 2008, vol 3, No.4, 303 - 308.
16. Standard Terminology Relating to Nanotechnology E 2456-06 (ASTM International, 2006).
17. Conner S D & Schmid S L, Regulated portals of entry into the cell, Nature, 422, 2003, 37-44.
18. Hillaireau H, Couvreur P, Nanocarriers' entry into the cell: relevance to drug delivery, Cellular and Molecular Life Sciences, 66, 2009, 2873-2896.
19. Aderem A & Underhill D M, Mechanisms of phagocytosis in macrophages. Annu. Rev. Immunol, 17, 1999, 593-623.
20. Claus V, Jahraus A, Tjelle T, Berg T, Kirschke H et. al., Lysosomal enzyme trafficking between phagosomes, endosomes, and lysosomes in J774 macrophages. Enrichment of cathepsin H in early endosomes, J Biol Chem, 273, 1998, 9842-9851.
21. Korn E D, Weisman R A, Phagocytosis of latex beads by Acanthamoeba. II. Electron microscopic study of the initial events, J Cell Biol, 34, 1967, 219-227.
22. Lenaerts V, Nagelkerke J F, Van Berkel T J, Couvreur P, Grislain L et. al., In vivo uptake of polyisobutyl cyanoacrylate nanoparticles by rat liver Kupffer, endothelial, and parenchymal cells, J Pharm Sci, 73, 1984, 980-982.
23. Heath T D, Lopez NG, Papahadjopoulos D, The effects of liposome size and surface charge on liposome-mediated delivery of methotrexategamma- aspartate to cells in vitro, Biochim Biophys Acta, 820, 1985, 74-84.
24. Kanaseki T, Kadota K, The "vesicle in a basket". A morphological study of the coated vesicle isolated from the nerve endings of the guinea pig brain, with special reference to the mechanism of membrane movements, J Cell Biol, 42, 1969, 202-220.
25. Pucadyil T J, Schmid S L, Conserved functions of membrane active GTPases in coated vesicle formation, Science, 325, 2009, 1217-1220.
26. Bareford L M, Swaan P W, Endocytic mechanisms for targeted drug delivery, Adv Drug Deliv Rev, 59, 2007, 748-758.
27. Slepnev V I, De Camilli P, Accessory factors in clathrin-dependent synaptic vesicle endocytosis, Nature Review Neuroscience, 1, 2000,161-172.
28. Rejman J, Oberle V, Zuhorn IS, Hoekstra D, Size dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis, Biochem Jour, 377, 2004,159-169.
29. Vasir J K, Labhasetwar V, Biodegradable nanoparticles for cytosolic delivery of therapeutics, Adv Drug Deliv Rev, 59, 2007,718-728.
30. Harush-Frenkel O, Debotton N, Benita S, Altschuler Y, Targeting of nanoparticles to the clathrinmediated endocytic pathway, Biochem Biophys Res Commun, 353, 2007, 26-32.
31. Huang M, Ma Z, Khor E, Lim L, Uptake of FITC chitosan nanoparticles by A549 cells, Pharm Res, 19, 2002, 1488-1494.
32. Nan A, Bai X, Son S J., Lee S B, Ghandehari H, Cellular uptake and cytotoxicity of silica nanotubes, Nano Letters, 8, 2008,2150-2154.
33. Mukherjee S, Ghosh RN, Maxfield FR (1997) Endocytosis. Physiol Rev 77:759-803
34. Marsh M, Helenius A, Virus entry: open sesame, Cell, 124, 2006, 729-740.
35. Bronich T K, Keifer P A, Shlyakhtenko L S, Kabanov A V, Polymer micelle with cross-linked ionic core, Journal of the American Chemical Society, 127, 2005, 8236-8237.
36. Sahay G, Kim JO, Kabanov AV, Bronich T K, The exploitation of differential endocytic pathways in normal and tumor cells in the selective targeting of nanoparticulate chemotherapeutic agents, Biomaterials, 31 (5), 2010, 923-933.
37. Nishikawa T, Iwakiri N, Kaneko Y, Taguchi A, Fukushima K et al., Nitric oxide release in human aortic endothelial cells mediated by delivery of amphiphilic polysiloxane nanoparticles to caveolae, Biomacromolecules, 10, 2009, 2074-2085.
38. Zhang L W, Monteiro-Riviere N A, Mechanisms of quantum dot nanoparticle cellular uptake, Toxicological Sciences, 110, 2009, 138-155.
39. Mukherjee S, Ghosh R N, Maxfield F R, Endocytosis, Physiol Rev, 77, 1997, 759-803.
40. Doherty G J, McMahon H T, Mechanisms of endocytosis, Annual Review of Biochemistry, 78, 2009, 857.